Needham & Company Downgrades Wright Medical (WMGI) to Buy

Summer Street Downgrades Wright Medical (WMGI) to Neutral

Summer Street downgraded Wright Medical (NASDAQ: WMGI) from Buy to Neutral. The change follows merger news yesterday.

For an analyst ratings summary and ratings history on Wright Medical click here. For more ratings news on Wright Medical click here.

Shares of Wright Medical closed at $31.64 yesterday.

Wright Medical (WMGI) Reports FDA Approvable of Augment Bone Graft, Lowers FY14 Sales Guidance

Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that its BioMimetic subsidiary has received an Approvable Letter from the U.S. Food and Drug Administration (FDA) for its Premarket Approval Application (PMA) for Augment® Bone Graft. The approvable letter indicates that FDA determined Augment® Bone Graft to be safe and effective as an alternative to autograft for ankle and/or hindfoot fusion indications and is approvable subject to customary preapproval facilities inspections.

Robert Palmisano, president and chief executive officer of Wright Medical, stated, Todays positive news on the approvability of Augment... More

Wright Medical Group (WMGI), Tornier N.V. (TRNX) to Merge in $3.3B Deal

Wright Medical Group, Inc. (NASDAQ: WMGI) and Tornier N.V. (NASDAQ: TRNX) announced today that they have entered into a definitive merger agreement under which Wright and Tornier will combine in an all stock transaction with a combined equity value of approximately $3.3 billion.

Under the terms of the agreement, which has been unanimously approved by the boards of directors of both Wright and Tornier, each outstanding share of Wright common stock will be exchanged for 1.0309 ordinary shares of Tornier. Upon completion of the merger, Wright... More

Wright Medical Group, Inc. (WMGI) halted with news pending

Wright Medical Group, Inc. (NASDAQ: WMGI) trading halted with news pending.